Experts at CHEST 2025 highlight rising costs, insurance complexity, and workforce shortages as major barriers to health care ...

Vaccine awareness, safety, and addressing misinformation are all important to improve adherence and public health outcomes, ...

Co-occurring mental health disorders are prevalent, with anxiety, ADHD, and depression being the most common among youth with ...

Sotatercept-csrk is approved for improving exercise capacity and reducing clinical worsening in PAH patients, following FDA ...

SGLT2 inhibitors represent one of the most remarkable therapeutic developments in heart failure care, transitioning from ...

Angiotensin receptor-neprilysin inhibitors (ARNIs) represent a significant advancement in heart failure therapy, combining an ...

Energy insecurity affects 43% of US adults, disproportionately impacting marginalized groups and leading to higher depression ...

Ratna Kiran Bhavaraju-Sanka, MD, and Beth Stein, MD, advocate for improved proactive management of myasthenia gravis (MG) for better patient outcomes.

More than 50% of patients with psoriasis are eligible for systemic treatment, and nearly 90% would switch to an effective oral therapy with a favorable safety profile.

Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...

Challenges in respiratory vaccine development include immune response elicitation, personalized data, and alternative delivery methods like oral or intranasal routes to improve compliance. Federal ...

“The results of our analysis showed that overall, patients with SCLC who survived to receive 3L treatment are a select group ...